![Biohaven Pharmaceutical Holding Company Ltd. logo](/logos/BHVN.webp)
Biohaven Pharmaceutical Holding Company Ltd.
NYSE:BHVN
Overview | Financials
Company Name | Biohaven Pharmaceutical Holding Company Ltd. |
Symbol | BHVN |
Currency | USD |
Price | 36.9 |
Market Cap | 3,488,609,025 |
Dividend Yield | 0% |
52-week-range | 16.45 - 62.21 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Vladimir Coric M.D. |
Website | https://www.biohavenpharma.com |
An error occurred while fetching data.
About Biohaven Pharmaceutical Holding Company Ltd.
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD